KRAS and carcinoma: KRAS mutations are frequently detected in SBAs in general (44%-54%6-8) and in SRC carcinomas of the colon-rectum (50%),41 whereas they appear to be never or very rarely detected in SB-PCCs (with no case of our series harboring KRAS point mutations).